Bank of Montreal
MJN

Bank of Montreal’s Mead Johnson Nutrition Company MJN Stock Holding History

Bank of Montreal’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-50,000
Closed -$4.45M – 4399
2017
Q1 		$4.45M Buy
+50,000
New +$4.11M ﹤0.01% 1126

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.55B AUM 27.24% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.54B AUM 37.12% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Bank of Montreal's MJN Position: Q2 2017 in Review

Bank of Montreal sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 569,014 shares — an estimated $50.7M sold.

Bank of Montreal first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $119M in Q4 2016. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Bank of Montreal reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Bank of Montreal sold 569,014 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $50.7M.
  • Bank of Montreal first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Bank of Montreal's Mead Johnson Nutrition Company position peaked at $119M in Q4 2016.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Bank of Montreal's 13F filing for Q2 2017, filed 11 Jul 2017.